We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Name | Symbol | Market | Type |
|---|---|---|---|
| Novartis AG | NYSE:NVS | NYSE | Depository Receipt |
| Price Change | % Change | Price | High Price | Low Price | Open Price | Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|
| 0.04 | 0.04% | 97.13 | 97.82 | 96.92 | 97.08 | 1,630,756 | 22:37:55 |
From May 2022 to May 2024
--Novartis AG has dropped a plan to conduct a major trial for its cholesterol drug Leqvio in the U.K. in collaboration with the National Health Service and will run a global trial instead, the Financial Times reports.
--The decision followed a low take-up of the drug during the initial U.K. rollout, the FT reports.
--The Swiss pharmaceutical company didn't immediately respond to a request for comment when contacted by Dow Jones Newswires.
Full story: https://on.ft.com/3luXQMA
Write to Adria Calatayud at adria.calatayud@dowjones.com
(END) Dow Jones Newswires
March 22, 2023 06:21 ET (10:21 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.
1 Year Novartis Chart |
1 Month Novartis Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
